Stevanato Group S.p.A. $STVN Shares Sold by First Eagle Investment Management LLC

First Eagle Investment Management LLC reduced its position in shares of Stevanato Group S.p.A. (NYSE:STVN – Free Report) by 39.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 736,956 shares of the company’s stock after selling 485,616 shares during the period. First Eagle Investment Management LLC owned approximately 0.24% of Stevanato Group worth $15,461,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Wellington Management Group LLP bought a new position in shares of Stevanato Group in the second quarter worth about $22,621,000. Ranger Investment Management L.P. acquired a new position in Stevanato Group during the 2nd quarter worth approximately $21,438,000. Cooper Investors PTY Ltd. increased its position in Stevanato Group by 4.4% during the 2nd quarter. Cooper Investors PTY Ltd. now owns 668,494 shares of the company’s stock worth $12,080,000 after purchasing an additional 28,265 shares in the last quarter. Schwartz Investment Counsel Inc. increased its position in Stevanato Group by 15.0% during the 3rd quarter. Schwartz Investment Counsel Inc. now owns 661,136 shares of the company’s stock worth $13,871,000 after purchasing an additional 86,385 shares in the last quarter. Finally, Riverbridge Partners LLC lifted its stake in Stevanato Group by 4.2% in the 3rd quarter. Riverbridge Partners LLC now owns 625,914 shares of the company’s stock valued at $13,132,000 after purchasing an additional 25,400 shares during the last quarter.

Wall Street Analyst Weigh In

Several research firms recently weighed in on STVN. Deutsche Bank started coverage on Stevanato Group in a report on Wednesday, October 7th. They set a “hold” rating on the stock. UBS Group lowered their target price on Stevanato Group from $23.00 to $16.00 and set a “neutral” rating for the company in a report on Wednesday, November 4th. Weiss Ratings upgraded Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, August 27th. William Blair downgraded Stevanato Group from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 4th. Finally, Citigroup cut their price target on Stevanato Group from $26.00 to $20.00 and set a “buy” rating on the stock in a research note on Wednesday, November 4th. Two research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.

Read Our Latest Stock Analysis on STVN

Stevanato Group Stock Performance

NYSE:STVN opened at €15.38 on Thursday. The company has a fifty day moving average of €18.84 and a 200-day moving average of €17.91. The firm has a market capitalization of $4.66 billion, a P/E ratio of 26.51, a P/E/G ratio of 1.57 and a beta of 0.80. The company has a quick ratio of 1.19, a current ratio of 1.73 and a debt-to-equity ratio of 0.22. Stevanato Group S.p.A. has a twelve month low of €12.05 and a twelve month high of €24.01.

Stevanato Group (NYSE:STVN – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported €0.16 EPS for the quarter, missing analysts’ consensus estimates of €0.17 by (€0.01). Stevanato Group had a net margin of 11.24% and a return on equity of 10.51%. The firm had revenue of €326.06 million during the quarter. As a group, sell-side analysts anticipate that Stevanato Group S.p.A. will post 0.67 EPS for the current year.

Insiders Place Their Bets

In related news, Director William J. Federici purchased 20,000 shares of the firm’s stock in a transaction dated Monday, November 9th. The shares were purchased at an average cost of €13.72 per share, for a total transaction of €274,400.00. Following the completion of the transaction, the director directly owned 46,991 shares in the company, valued at approximately €644,716.52. This represents a 74.10% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Donald E. Morel, Jr. acquired 25,000 shares of the stock in a transaction that occurred on Friday, November 6th. The stock was acquired at an average price of €13.07 per share, for a total transaction of €326,750.00. Following the transaction, the director directly owned 62,424 shares of the company’s stock, valued at €815,881.68. This represents a 66.80% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 0.70% of the company’s stock.

Stevanato Group Profile

(Free Report)

Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.

Recommended Stories

Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVN – Free Report).

Institutional Ownership by Quarter for Stevanato Group (NYSE:STVN)

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.